Meningococcal Vaccine Recommendations | Meningococcal | CDC The following summarizes CDC's current age- and risk-based meningococcal vaccine recommendations by vaccine type Access the official, full text of CDC's current and historical meningococcal vaccine recommendations
Meningococcal B Vaccine Recommendations by Age and Risk Factor Teens and young adults ages 16 through 23 years based on shared clinical decision- making (those who want to be vaccinated based on the risk and benefits of the vaccine) The preferred age for vaccination is 16 through 18 years Administer either Bexsero or Trumenba: Give 2 doses, 6 months apart
Meningococcal Disease and the Men B Vaccine | AAFP Boosters: For individuals at persistent increased risk, a booster is recommended 1 year after the primary series, then every 2–3 years Note: MenB vaccines are not interchangeable The same
Meningococcal B Vaccine: What You Need to Know People who are moderately or severely ill should usually wait until they recover before getting meningococcal B vaccine Your health care provider can give you more information
CDC Updates Recommendations for the Meningitis Vaccine Teenagers who didn’t get a dose at age 11 or 12 may get the vaccine at age 13 or older A doctor can help you learn whether a booster dose will be necessary and when to get it
CDC OKs MenB vaccine schedule change, 2025 immunization schedule ACIP is considering a single dose for some age groups and a two-dose schedule for some age groups older than 14 years The group also is looking at changing the wording on the age for routine vaccination
Serogroup B Meningococcal Vaccine (MenB) - UF Health People who are moderately or severely ill should usually wait until they recover before getting meningococcal B vaccine Your health care provider can give you more information